Russell Investments Group Ltd. Sells 138,382 Shares of Healthpeak Properties, Inc. $DOC

Russell Investments Group Ltd. trimmed its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 3.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,271,632 shares of the real estate investment trust’s stock after selling 138,382 shares during the period. Russell Investments Group Ltd.’s holdings in Healthpeak Properties were worth $91,418,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in DOC. New York Life Investment Management LLC boosted its position in shares of Healthpeak Properties by 65.8% during the fourth quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock worth $2,510,000 after buying an additional 61,952 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al grew its holdings in shares of Healthpeak Properties by 176.0% during the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 320,040 shares of the real estate investment trust’s stock worth $5,146,000 after buying an additional 204,100 shares in the last quarter. Swedbank AB raised its position in Healthpeak Properties by 433.4% in the 4th quarter. Swedbank AB now owns 849,215 shares of the real estate investment trust’s stock valued at $13,655,000 after buying an additional 690,000 shares during the last quarter. Nan Fung Trinity HK Ltd. acquired a new stake in Healthpeak Properties in the 4th quarter valued at approximately $2,654,000. Finally, JPMorgan Chase & Co. raised its position in Healthpeak Properties by 8.6% in the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock valued at $493,251,000 after buying an additional 2,438,278 shares during the last quarter. 93.57% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

DOC has been the subject of a number of recent research reports. UBS Group upped their price target on Healthpeak Properties from $19.00 to $21.50 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Wells Fargo & Company lifted their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a report on Wednesday, July 15th. Raymond James Financial initiated coverage on shares of Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Finally, Citigroup increased their target price on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Tuesday. Four equities research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $21.44.

Healthpeak Properties Price Performance

NYSE:DOC opened at $20.78 on Friday. Healthpeak Properties, Inc. has a 52-week low of $15.70 and a 52-week high of $22.95. The company has a market cap of $14.33 billion, a P/E ratio of 59.38, a P/E/G ratio of 3.20 and a beta of 1.01. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. The stock’s 50-day simple moving average is $21.33 and its 200 day simple moving average is $18.90.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The firm had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. During the same period in the prior year, the firm posted $0.46 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be paid a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.9%. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.